RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)

ETR:RHK Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,596	1,464	1,446	1,402	1,360
Other Revenue	272.24	270.75	215.07	189.2	185.9
Revenue	1,868	1,735	1,661	1,591	1,546
Revenue Growth (YoY)	7.67%	4.43%	4.40%	2.92%	4.40%
Cost of Revenue	1,658	1,532	1,457	1,409	1,387
Gross Profit	209.77	202.88	203.78	182.63	159.02
Selling, General & Admin	4.9	4.8	4.3	3.8	4
Other Operating Expenses	95.1	93.59	98.63	80.47	78.25
Operating Expenses	162.62	163.88	172.47	154.91	151.7
Operating Income	47.15	39	31.31	27.72	7.33
Interest Expense	-3.4	-3.7	-4.1	-3.2	-7.4
Interest & Investment Income	11.1	10.5	1.3	0.5	0.8
Earnings From Equity Investments	0.11	0.02	0.08	0.09	0.09
Other Non Operating Income (Expenses)	1.44	2.21	2.04	1.2	1.04
EBT Excluding Unusual Items	56.4	48.03	30.63	26.31	1.85
Gain (Loss) on Sale of Investments	-	-	-	-0.55	-0.19
Gain (Loss) on Sale of Assets	-0.2	-0.3	-0.2	-0.1	-1.03
Other Unusual Items	-	-	3.2	1.7	3.3
Pretax Income	56.2	47.73	33.63	27.36	3.93
Income Tax Expense	11	7.56	6.69	-2.87	1.47
Earnings From Continuing Operations	45.21	40.17	26.94	30.23	2.46
Minority Interest in Earnings	-1.86	-1.46	-1.8	-1.93	-1.01
Net Income	43.35	38.71	25.14	28.3	1.45
Net Income to Common	43.35	38.71	25.14	28.3	1.45
Net Income Growth	11.98%	53.96%	-11.14%	1850.03%	-96.65%
Shares Outstanding (Basic)	67	67	67	67	67
Shares Outstanding (Diluted)	67	67	67	67	67
EPS (Basic)	0.65	0.58	0.38	0.42	0.02
EPS (Diluted)	0.65	0.58	0.38	0.42	0.02
EPS Growth	11.98%	53.96%	-10.56%	2000.00%	-96.91%
Free Cash Flow	57.2	46.2	2.1	19.7	16.3
Free Cash Flow Per Share	0.85	0.69	0.03	0.29	0.24
Dividend Per Share	0.100	-	0.150	-	-
Gross Margin	11.23%	11.70%	12.27%	11.48%	10.29%
Operating Margin	2.52%	2.25%	1.88%	1.74%	0.47%
Profit Margin	2.32%	2.23%	1.51%	1.78%	0.09%
Free Cash Flow Margin	3.06%	2.66%	0.13%	1.24%	1.05%
EBITDA	106.55	101.5	97.61	94.82	73.73
EBITDA Margin	5.70%	5.85%	5.88%	5.96%	4.77%
D&A For EBITDA	59.4	62.5	66.3	67.1	66.4
EBIT	47.15	39	31.31	27.72	7.33
EBIT Margin	2.52%	2.25%	1.88%	1.74%	0.47%
Effective Tax Rate	19.57%	15.84%	19.89%	-	37.36%
Revenue as Reported	1,869	1,736	1,666	1,600	1,556

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.